Newsoara Biopharma Co., Ltd.

Prime Medicine, Inc. ’s $175m initial public offering late on 19 October was only the second IPO in the US launched by a biopharmaceutical firm during the second half of 2022 that raised more than $10

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis

The biopharmaceutical industry set a new record in venture capital financing raised in a single year, with one quarter left to go in 2021. Drug developers raised $28bn in VC funding through the third

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OliX, Hansoh Ink Licensing Pact To Deve